Evidence map›Paper›PMID 41654138›Full record

ArticleThe Journal of biological chemistry2026

Preferential use of alkyl-acyl phosphatidylinositol for GPI biosynthesis and diagnostic potential of lipidomics for inherited GPI deficiencies.

Xueying Li, Kae Imanishi, Saori Umeshita, Yuya Senoo, Paula A Guerrero, Daniel Varon Silva, Kazutaka Ikeda, Taroh Kinoshita, Yoshiko Murakami

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xueying LiLaboratory of Immunoglycobiology, Research Institute for Microbial Diseases, The University of Osaka, Osaka, Japan; Department of Virology, Reserch Institute for Microbial Diseases, The University of Osaka, Osaka, Japan.
Kae ImanishiLaboratory of Immunoglycobiology, Research Institute for Microbial Diseases, The University of Osaka, Osaka, Japan.
Saori UmeshitaLaboratory of Immunoglycobiology, Research Institute for Microbial Diseases, The University of Osaka, Osaka, Japan.
Yuya SenooLaboratory of Biomolecule Analysis, Kazusa DNA Research Institute, Chiba, Japan.
Paula A GuerreroSchool of Life Sciences FHNW, Institute of Chemistry and Bioanalytics, Muttenz, Switzerland.
Daniel Varon SilvaSchool of Life Sciences FHNW, Institute of Chemistry and Bioanalytics, Muttenz, Switzerland.
Kazutaka IkedaLaboratory of Biomolecule Analysis, Kazusa DNA Research Institute, Chiba, Japan.
Taroh KinoshitaLaboratory of Immunoglycobiology, Research Institute for Microbial Diseases, The University of Osaka, Osaka, Japan; Center for Infectious Disease Education and Research, The University of Osaka, Osaka, Japan.
Yoshiko MurakamiLaboratory of Immunoglycobiology, Research Institute for Microbial Diseases, The University of Osaka, Osaka, Japan. Electronic address: yoshiko@biken.osaka-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycosylphosphatidylinositol-anchored proteins (GPI-APs) are attached to the cell surface via a glycolipid anchor, GPI, whose conserved core is synthesized from phosphatidylinositol (PI) in the endoplasmic reticulum through a series of enzymatic reactions. Most PI species in mammalian cells contain diacylglycerol, whereas GPI-APs predominantly possess 1-alkyl-2-acylglycerol. The basis for this characteristic lipid structure has remained unclear. Lipidomic analysis revealed that 1-alkyl-2-acyl PIs, although minor components of cellular PI, are preferentially used by GPI-N-acetylglucosaminyltransferase, which catalyzes the first step of GPI biosynthesis. GPI intermediates containing 1-alkyl-2-acylglycerol were further enriched in subsequent biosynthetic steps, resulting in mature GPIs primarily harboring this lipid species. We demonstrate that a 1-alkyl-containing precursor lipid derived from peroxisomes, likely 1-alkyl-glyceronephosphate, contributes to the formation of 1-alkyl-2-acyl PIs. Disruption of glyceronephosphate O-acyltransferase (GNPAT) or alkylglycerone phosphate synthase (AGPS), the first two enzymes of the peroxisomal ether-lipid pathway, abolished 1-alkyl-2-acyl PI, yielding GPI-APs containing only diacylglycerol. Lipidomic profiling of GPI biosynthetic intermediates in GPI-defective cells revealed accumulation of defective-step-specific intermediates, enabling the use of this approach for diagnosing inherited GPI deficiency (IGD).

Indexed as

GlycosylphosphatidylinositolsLipidomicsPhosphatidylinositolsAnimalsHumansSeizuresGlycosylphosphatidylinositolsPhosphatidylinositolsalkyl-lipidglycosylphosphatidylinositol(GPI)-anchorGPI biosynthesis genesGPI intermediateslipidomicslipid remodelingperoxisomephosphatidylinositol (PI)

Identifiers

PMID41654138
PMCPMC12969624

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.